Fosun Pharm Raises Holding in Tongjitang

导出

摘要 Fosun Pharm Raises Holding in Tongjitang Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharm, SH: 600196) announcedMarch 10th that it have purchased aggregate 5 388 346 American depositaryshares (ADSs) as of March 3rd, 2009 in Tongjitang Chinese Medicines Company(NYSE: TCM) via its fully-owned subsidiary Fosun Pharmaceutical (Hong Kong)Limited for US$16.93 million. As a result, Fosun Pharm raised the stake to 15.94% forTCM’s total common shares.

出处《China Chemical Reporter》 2009年第9期5-7,共6页 中国化工报导（英文版）

关键词 PHARM SUBSIDIARY STAKE OWNED SHARES raised purchas

分类号 F832.51 [经济管理—金融学]

引文网络
相关文献

1ICBC to Open Subsidiary Bank in the U.S.[J].China's Foreign Trade,2007(20):50-50.
2REN WEI.Proceeds Barred From Shares[J].China International Business,2007(4):46-46.
3深圳证券交易所主要统计指标[J].中国经济景气月报,2013,0(8):80-81.
4任侃.中国在更多的城市试行B股[J].World Economy & China,1995,3(3):37-37.
5HC International： HK$125 Million Raised after Listed[J].China's Foreign Trade,2004(3):21-21.
6Jiang Yong.China's Economic Security at Stake[J].Contemporary International Relations,2007,17(3):27-42.
7Foreign, Private Stake to Rise in Financial Firms[J].China's Foreign Trade,2005(21):42-42.
8China Construction Bank approved to set up London subsidiary[J].China's Foreign Trade,2009(1):17-17.
9360Buy Raises $150M[J].投资与合作,2010(2):138-141.
10Go Trade Stocks via Gotrade.com[J].China Today,2001,50(6):70-71.

China Chemical Reporter

2009年第9期

浏览历史

内容加载中请稍等...

Fosun Pharm Raises Holding in Tongjitang

相关作者

相关机构

相关主题

浏览历史